Effects of gadolinium contrast agent on aortic blood flow and myocardial strain measurements by phase-contrast cardiovascular magnetic resonance

Effects of gadolinium contrast agent on aortic blood flow and myocardial strain measurements by phase-contrast cardiovascular magnetic resonance

<p>Abstract</p> <p>Background</p> <p>Quantitative blood flow and aspects of regional myocardial function such as myocardial displacement and strain can be measured using phase-contrast cardiovascular magnetic resonance (PC-CMR). Since a gadolinium-based contrast agent i...

Full description

Bibliographic Details
Main Authors:	Bergvall Erik, Bloch Karin, Hedström Erik, Ståhlberg Freddy, Arheden Håkan
Format:	Article
Language:	English
Published:	BMC 2010-11-01
Series:	Journal of Cardiovascular Magnetic Resonance
Online Access:	http://www.jcmr-online.com/content/12/1/70

Similar Items

1080 Strain analysis using magnetic resonance imaging can independently identify affected vessel after acute coronary syndrome
by: Arheden Håkan, et al.
Published: (2008-10-01)

Cardiovascular magnetic resonance of the myocardium at risk in acute reperfused myocardial infarction: comparison of T2-weighted imaging versus the circumferential endocardial extent of late gadolinium enhancement with transmural projection
by: Hedström Erik, et al.
Published: (2010-03-01)

Effects of caffeine abstinence on adenosine induced coronary flow reserve quantified on phase contrast velocity encoded MRI of the coronary sinus
by: Stahlberg Freddy, et al.
Published: (2010-01-01)

New gadolinium contrast agents for MRI
by: Elemento, Elisa
Published: (2008)

Gadolinium Endohedral Metallofullerenes for Future Magnetic Resonance Imaging Contrast Agents
by: Ye, Youqing
Published: (2014)

Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance.
by: Steven C Dinger, et al.
Published: (2016-01-01)

Evolution of left ventricular strain after a first time myocardial infarction. A study using velocity encoded magnetic resonance imaging
by: Hedström Erik, et al.
Published: (2009-01-01)

New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging.
by: Ketan B Ghaghada, et al.
Published: (2009-10-01)

THE DIAGNOSTIC EFFICACY AND SAFETY OF MACROCYCLIC GADOLINIUM-BASED MAGNETIC RESONANCE CONTRAST AGENTS
by: V. O. Panov, et al.
Published: (2017-07-01)

Chiral gadolinium complexes as potential contrast agents
by: Woods, Mark
Published: (1998)

Endocardial extent by contrast enhanced cardiac magnetic resonance imaging is not an accurate method for assessing myocardium at risk; validation with T2-weighted cardiac magnetic resonance imaging
by: Carlsson Marcus, et al.
Published: (2010-01-01)

Gadolinium-porphyrins: new potential magnetic resonance imaging contrast agents for melanoma detection
by: Daryoush Shahbazi-Gahrouei
Published: (2006-11-01)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
by: Nat Sakol, et al.
Published: (2020-06-01)

Is it safe to use gadolinium-based contrast agents in MRI?
by: R Pullicino, et al.
Published: (2017-09-01)

Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement
by: Jennifer Erley, et al.
Published: (2019-08-01)

Beyond late gadolinium enhancement: the key role of diffuse myocardial fibrosis in severe aortic stenosis - an Equilibrium Contrast CMR study
by: Mcgregor Christopher, et al.
Published: (2011-02-01)

The dynamics of extracellular gadolinium-based contrast agent excretion into pleural and pericardial effusions quantified by T1 mapping cardiovascular magnetic resonance
by: Simon Thalén, et al.
Published: (2019-11-01)

Myocardial tissue characterisation using gadolinium cardiovascular magnetic resonance
by: Moon, James Charles Connor
Published: (2005)

Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents
by: Thomas J. Clough, et al.
Published: (2019-03-01)

Human Aortic Endothelial Cell Labeling with Positive Contrast Gadolinium Oxide Nanoparticles for Cellular Magnetic Resonance Imaging at 7 Tesla
by: Yasir Loai, et al.
Published: (2012-03-01)

MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study
by: Bandettini W Patricia, et al.
Published: (2012-11-01)

Longitudinal strain from velocity encoded cardiovascular magnetic resonance: a validation study
by: Heiberg Einar, et al.
Published: (2013-01-01)

Intra-arterial gadolinium as an alternative to iodinated contrast agents in thrombectomy
by: A. de Albóniga-Chindurza, et al.
Published: (2020-11-01)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
by: Kim Hyo Jeong, et al.
Published: (2010-01-01)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
by: Atiya Fatima, et al.
Published: (2021-09-01)

Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
by: Nucera E, et al.
Published: (2021-03-01)

Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
by: Caterina Beatrice Monti, et al.
Published: (2020-04-01)

Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis
by: Stremmel Wolfgang, et al.
Published: (2010-08-01)

Molecular imaging of tumour apoptosis using magnetic resonance and a targeted gadolinium-based contrast agent
by: Krishnan, Anant Subramanian
Published: (2007)

2092 Myocardial field distortions during first pass of a gadolinium based contrast agent in perfusion studies
by: Wage Ricardo, et al.
Published: (2008-10-01)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents.
by: Henning Richter, et al.
Published: (2020-01-01)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.
by: Cyprian Olchowy, et al.
Published: (2017-01-01)

Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement
by: Scott D Swanson, et al.
Published: (2008-06-01)

PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
by: Charmainne Cruje, et al.
Published: (2021-08-01)

Acute respiratory distress syndrome after the use of gadolinium contrast agent
by: Bugra Kerget, et al.
Published: (2018-01-01)

1107 Quantification of left ventricular strain using turbo field echo produces less variable data than using fast field echo
by: Soneson Helen, et al.
Published: (2008-10-01)

Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy
by: Frank J. Raucci, et al.
Published: (2021-04-01)

Myocardium at risk and myocardial salvage after acute infarction in humans; quantification by magnetic resonance imaging
by: Arheden Hakan, et al.
Published: (2009-01-01)

In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent
by: Shih-Hsien Chen, et al.
Published: (2013-05-01)

Quantifying coronary sinus flow and global LV perfusion at 3T
by: Bloch Karin, et al.
Published: (2009-06-01)